<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Perm Medical Journal</journal-id><journal-title-group><journal-title xml:lang="en">Perm Medical Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Пермский медицинский журнал (сетевое издание "Perm medical journal")</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0136-1449</issn><issn publication-format="electronic">2687-1408</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">676832</article-id><article-id pub-id-type="doi">10.17816/pmj42163-70</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">COVID-19 immune trace: predictors of rheumatoid arthritis development</article-title><trans-title-group xml:lang="ru"><trans-title>Иммунный след COVID-19: предикторы развития ревматоидного артрита</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-3690-3041</contrib-id><name-alternatives><name xml:lang="en"><surname>Karibova</surname><given-names>A. K.</given-names></name><name xml:lang="ru"><surname>Карибова</surname><given-names>А. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Head of the Department of Rheumatology</p></bio><bio xml:lang="ru"><p>заведующая отделением ревматологии</p></bio><email>solomon687@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4860-0112</contrib-id><name-alternatives><name xml:lang="en"><surname>Khlynova</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Хлынова</surname><given-names>О. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Professor, Head of the Department of Hospital Therapy and Cardiology</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующая кафедрой госпитальной терапии и кардиологии</p></bio><email>solomon687@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5446-1775</contrib-id><name-alternatives><name xml:lang="en"><surname>Kudaev</surname><given-names>M. T.</given-names></name><name xml:lang="ru"><surname>Кудаев</surname><given-names>М. Т.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio><p>DSc (Medicine), Professor, Head of the Department of Therapy</p></bio><email>solomon687@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8935-220X</contrib-id><name-alternatives><name xml:lang="en"><surname>Akhmedkhanov</surname><given-names>S. Sh.</given-names></name><name xml:lang="ru"><surname>Ахмедханов</surname><given-names>С. Ш.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Professor, Head of the Department of Internal Diseases of the Pediatric and Dental Faculties</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующий кафедрой внутренних болезней педиатрического и стоматологического факультетов</p></bio><email>solomon687@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-6333-3790</contrib-id><name-alternatives><name xml:lang="en"><surname>Mustafaev</surname><given-names>D. I.</given-names></name><name xml:lang="ru"><surname>Мустафаев</surname><given-names>Д. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Resident</p></bio><bio xml:lang="ru"><p>врач-ординатор</p></bio><email>solomon687@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">City Clinical Hospital</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Ye.A. Vagner Perm State Medical University</institution></aff><aff><institution xml:lang="ru">Пермский государственный медицинский университет имени академика Е.А. Вагнера</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Dagestan State Medical University</institution></aff><aff><institution xml:lang="ru">Дагестанский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-02-12" publication-format="electronic"><day>12</day><month>02</month><year>2025</year></pub-date><volume>42</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>63</fpage><lpage>70</lpage><history><date date-type="received" iso-8601-date="2025-03-04"><day>04</day><month>03</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-03-04"><day>04</day><month>03</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://permmedjournal.ru/PMJ/article/view/676832">https://permmedjournal.ru/PMJ/article/view/676832</self-uri><abstract xml:lang="en"><p><bold>Objective</bold><bold>. </bold>To assess the effect of coronavirus infection on the development of true arthritis in patients with post-COVID joint syndrome</p> <p><bold>Materials and methods</bold><bold>.</bold> Factors contributing to the development of true rheumatic disease in patients with confirmed coronavirus infection were evaluated in a prospective cohort study. General clinical and immunological tests, including markers of rheumatoid arthritis were determined.</p> <p><bold>Results</bold><bold>. </bold>On the basis of the results of this study, it was found out that COVID-19 may act as a trigger for autoimmune diseases.</p> <p><bold>Conclusions</bold><bold>. </bold>The results of the study indicate the trigger role of COVID-19 in the development of autoimmune diseases. Preventive measures aimed at early detection of rheumatoid arthritis among patients with SARS-COV2 are control of leukocyte count and rheumatoid arthritis markers. A follow-up with a rheumatologist with a periodic monitoring of clinical and immunological parameters is recommended if joint syndrome is revealed.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель. </bold>Оценка влияния коронавирусной инфекции на развитие истинного артрита у пациентов с постковидным суставным синдромом.</p> <p><bold>Материалы и методы. </bold>У пациентов с подтвержденной коронавирусной инфекцией в пропективном когортном исследовании оценивались факторы, способствующие развитию истинного ревматического заболевания. Определены общеклинические и иммунологические тесты, маркеры ревматоидного артрита.</p> <p><bold>Результаты. </bold>По результатам проведенного исследования установлено, что COVID-19 может выступить в роли триггера аутоиммунных заболеваний.</p> <p><bold>Выводы.</bold> Результаты проведенного исследования указывают на триггерную роль COVID-19 в развитии аутоиммунных заболеваний. Профилактическим методами, направленными на раннее выявление ревматоидного артрита среди пациентов с SARS-CoV-2 является контроль показателей лейкоцитов, маркеров ревматоидного артрита. При выявлении суставного синдрома рекомендовано наблюдение у ревматолога с периодическим контролем данных клинических и иммунологических показателей.</p></trans-abstract><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>post-COVID syndrome</kwd><kwd>autoimmunity</kwd><kwd>immune disorders</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>постковидный синдром</kwd><kwd>аутоиммунитет</kwd><kwd>иммунные нарушения</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Korzeniowska A., Bryl E. Infectious agents in the pathogenesis of autoimmune rheumatic diseases. Translational Research. 2025; 256: 39–45. DOI: 10.1016/j.trsl.2024.12.004</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sundaresan B., Shirafkan F., Ripperger K., Rattay K. The Role of Viral Infections in the Onset of Autoimmune Diseases. Viruses. 2023; 15 (3): 782–788. DOI: 10.3390/v15030782</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Habibi M.A., Nezhad Shamohammadi F., Rajaei T. Immunopathogenesis of viral infections in neurological autoimmune disease. BMC Neurol. 2023; 23 (1): 2–15. DOI: 10.1186/s12883-023-03239-x</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bouzid S., Ben Abdelghani K., Miledi S., Fazaa A., Laatar A. Can SARS-CoV-2 infection trigger rheumatoid arthritis? A case report. Clin Case Rep. 2022; 10 (4): 1–11. DOI: 10.1002/ccr3.5748</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Dewanjee S., Kandimalla R., Kalra R.S. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges. COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association. Therapeutic Options and Challenges 2021; 10 (3291): 2–21. DOI: 10.3390/cells10123291</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Mukarram M.S., Ishaq G.M., Sethar S., Afsar N., Riaz A., &amp; Ishaq K. COVID-19: An Emerging Culprit of Inflammatory Arthritis. Case reports in rheumatology 2021; 6610340: 1–8. DOI: 10.1155/2021/6610340</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Ahmed S., Zimba O., Gasparyan A.Y. COVID-19 and the clinical course of rheumatic manifestations. Clinical rheumatology 2021; 40 (7): 2611–2619 DOI: 10.1007/s10067-021-05691-x</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Карибова А.К., Ахмедханов С.Ш., Кудаев М.Т., Малаев Х.М. Клинико-иммунологические нарушения при COVID-19. Современная ревматология 2024; 18 (5): 90–94. DOI: 10.14412/1996-7012-2024-5-90-94 / Karibova A.K., Akhmedkhanov S.Sh., Kudaev M.T., Malaev H.M. Clinical and immunological disorders in COVID-19. Modern rheumatology 2024; 18 (5): 90–94. DOI: 10.14412/1996-7012-2024-5-90-94 (in Russian).</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Baimukhamedov C., Barskova T., Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. The Lancet. Rheumatology 2021; 3 (5): 324–325. DOI: 10.1016/S2665-9913(21)00067-9</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Marín J.S., Mazenett-Granados E.A., Salazar-Uribe J. et al. CIncreased incidence of rheumatoid arthritis after COVID-19. Autoimmun Rev. 2023; 22 (10): 103409. DOI: 10.1016/j.autrev.2023.103409</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Maroua S., Takoua M., Maissa A., Wafa T., Rim., Leila., Imen., Bassem L. Rheumatoid arthritis occurring after coronavirus disease 2019 (COVID-19) infection: Case based review. The Egyptian Rheumatologist 2022; 44 (3): 275–278 DOI: 10.1016/j.ejr.2022.03.001</mixed-citation></ref></ref-list></back></article>
